Aigen Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,138
Closed -$349K 889
2023
Q4
$349K Buy
+1,138
New +$307K 0.06% 443
2023
Q3
Sell
-1,235
Closed -$297K 981
2023
Q2
$297K Sell
1,235
-671
-35% -$139K 0.04% 498
2023
Q1
$358K Buy
1,906
+613
+47% +$127K 0.05% 386
2022
Q4
$275K Buy
+1,293
New +$258K 0.04% 382
2020
Q1
Sell
-8,507
Closed -$715K 1441
2019
Q4
$715K Buy
+8,507
New +$658K 0.12% 249

Other funds holding MEDP

Aigen Investment Management's MEDP Position: Q1 2024 in Review

Aigen Investment Management sold out of Medpace (MEDP) in Q1 2024, closing a stake of 1,138 shares — an estimated $349K sold.

Aigen Investment Management first reported a position in MEDP in Q4 2019 and held it in 5 quarters. The position peaked at $715K in Q4 2019. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

  • Aigen Investment Management reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
  • Aigen Investment Management sold 1,138 Medpace shares in Q1 2024, an estimated $349K.
  • Aigen Investment Management first reported a position in Medpace in Q4 2019 and held it in 5 quarters.
  • Aigen Investment Management's Medpace position peaked at $715K in Q4 2019.
  • 597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.